BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 18, 2016
View Archived Issues
AZD-7325, increases test stimulus intensity at 2-h post-dose in a phase I crossover study
Read More
Exploring optimal dosing of lonafarnib with ritonavir for the treatment of chronic delta hepatitis
Read More
DWN-10899, a novel Nav1.7 blocker significantly blocks neuropathic pain in mouse model
Read More
Sanford-Burnham Medical Research Institute patents APJ agonists
Read More
Janssen Pharmaceutica discloses TARPgamma8 modulators
Read More
Eli Lilly and Company describes BACE1 inhibitors
Read More
Chinese researchers develop antiviral agents
Read More
Sanford-Burnham Medical Research Institute presents EphA4 inhibitors
Read More
Gilead Sciences returns GS-4774 rights to GlobeImmune
Read More
Janssen submits application to FDA seeking approval of guselkumab
Read More
Agilis Biotherapeutics' AGIL-AADC wins FDA rare pediatric disease designation
Read More
FDA approves Intrarosa to treat dyspareunia in postmenopausal women
Read More
Endo's CCH significantly improves cellulite in phase II study
Read More
Resverlogix's apabetalone shows favorable PK profile in severe renal impairment
Read More
Cellectar Biosciences reports advances in Pierre Fabre research collaboration
Read More
ProMetic Life Sciences's PBI-4050 shows efficacy in phase II study in IPF
Read More
Celgene acquires marizomib assets from Triphase Accelerator
Read More
Novan reports promising preclinical data on SB-414 for psoriasis
Read More
Immune Pharmaceuticals secures new financing
Read More
Namodenoson approved as generic name for CF-102
Read More
Launch of International PSC Genome Project for primary sclerosing cholangitis
Read More
FDA awards fast track designation to Eisai's BACE inhibitor for Alzheimer's
Read More